July/August 2010

EDITOR'S PAGE: Rising to the Challenge of Diabetic Retinopathy

Allen C. Ho, MD, and Robert L. Avery, MD

Retinal Prosthesis Technology

Clinical trials demonstrate that both epiretinal and subretinal approaches provide visual function to blind patients.

Jennifer Kreatsoulas, PHD, Senior Associate Editor

Fellows' Focus: Ergonomics for the Retina Specialist

Allen Chiang, MD; Paul S. Baker, MD; and Eugene A. Milder, MD; With Sunir J. Garg, MD

GLOBAL PERSPECTIVES: Vital Dyes for Staining Intraocular Membranes and Tissues During Vitrectomy

An overview of vital dyes and their characteristics.

Mauricio Maia MD, PHD; Michel EID Farah, MD, PHD; Eduardo B. Rodrigues, MD; Andre Maia, MD; Octaviano Magalhaes JR., MD; and Acacio Lima, PHD

RETINA PEARLS: Monitoring for Hydroxychloroquine Retinal Toxicity

Multifocal ERG is useful in detecting early maculopathy.

Todd Klesert, MD, PHD

A Conservative Approach to 23-gauge Vitrectomy

Andrew A. Moshfeghi, MD, MBA, and Thomas Albini, MD

CASE REPORTS IN OCULAR ONCOLOGY: Primary Transpupillary Thermotherapy for Choroidal Melanoma

This is still a valuable treatment in properly selected cases.

Brad E. Kligman, BS; Carol L. Shields, MD; and Jerry A. Shields, MD

Update on the Diabetic Retinopathy Clinical Research Network

Recent data and status of some ongoing DRCR.net protocols.

Sharon D. Solomon, MD, and Neil M. Bressler, MD

Emerging Treatments for Diabetic Macular Edema

A review of agents in clinical trials.

Avner Ingerman, MD, MSC, and Daniel Dewey-Mattia

Ultra-widefield Fluorescein Angiography in the Diagnosis and Management of Diabetic Retinopathy

Ivan J. Suner, MD

Surgical Management of Young Diabetics with Tractional Retinal Detachment

These “hot” eyes can be challenging even for experienced surgeons.

Tom H. Williamson, MD, MBCHB, FRCS, FRCOPHTH, MD

Cataract Surgery in Diabetic Patients

Excellent outcomes can be achieved in these patients with appropriate attention to details.

Uday Devgan, MD, FACS, FRCS(GLASG)

Point/Counterpoint Early vs Late Pharmacologic Therapy for RVO

Nancy M. Holekamp, MD and Michael S. Ip, MD

Pharmacogenomics for the Retina Specialist

This specialized discipline may play an important role in improving patient outcomes.

Stephen G. Schwartz, MD, MBA, and M. Elizabeth Fini, PHD

Uncoating Coats

Management of advanced disease may include surgery.

Manish Nagpal, MS, DO, FRCS(UK), and Pravin Jain, FRF, DNB

Early Impressions of the 25+ System and EdgePlus Blade for MIVS

Robert L. Avery, MD

INNOVATIONS

5 Questions with Bill Aylward, MD

Dr. Aylward is a Consultant Vitreoretinal Surgeon and former Medical Director at Moorfields Eye Hospital in London. He is also President of the European Society of Retina Specialists (Euretina).